The determination of optimal dosage requires individual titration. Start therapy at a low dosage and increase gradually until optimum effect is achieved (usually between 40 to 80 mg daily).
The following dosage titration schedule is suggested:
5 mg t.i.d. for 3 days
10 mg t.i.d. for 3 days
15 mg t.i.d. for 3 days
20 mg t.i.d. for 3 days
Thereafter additional increases may be necessary but the total daily dose should not exceed a maximum of 80 mg daily (20 mg q.i.d.).
The lowest dose compatible with an optimal response is recommended. If benefits are not evident after a reasonable trial period, patients should be slowly withdrawn from the drug (see WARNINGS Abrupt Drug Withdrawal).
10 mg tablets are supplied as scored, flat bevelled edge, round, white tablets debossed “BN scoreline 10″ on one side and “G” on the other
Bottles of 100 NDC 57315-001-01
Bottles of 500 NDC 57315-001-04
Bottles of 1000 NDC 57315-001-02
20 mg tablets are supplied as scored, flat bevelled edge, round, white tablets debossed “BN scoreline 20″ on one side and “G” on the other
Bottles of 100 NDC 57315-002-01
Bottles of 500 NDC 57315-002-04
Bottles of 1000 NDC 57315-002-02
Dispense in a well-closed container, as described in the USP, using a child-resistant closure.
Store at 20° to 25°C (68° to 77°F) (see USP Controlled Room Temperature).
Manufactured in Australia by:
15 Garnet Street
Carole Park Qld 4300
1646/3 Revised September 2008
| BACLOFEN |
| BACLOFEN |
|Labeler — ALPHAPHARM PTY LTD|
Revised: 09/2008 ALPHAPHARM PTY LTD
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.